TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/9/25 16:42 | 9/5/25 | NAUT | Nautilus Biotechnology, Inc. | Electr | LabEq | Laboratory Analytical Instrum | Patel Sujal M | WA | DOT | CEO,P,,S | P.m | 136 | 0.6779 | 0 | 200 | 1 | 17,436 | D | |||||||||||||||
3/21/25 16:44 | 3/19/25 | NAUT | Nautilus Biotechnology, Inc. | Electr | LabEq | Laboratory Analytical Instrum | Patel Sujal M | WA | DOT | CEO,P,,S | P.m | 77 | 0.9959 | 0 | 77 | 0 | 17,236 | D | |||||||||||||||
3/11/24 20:21 | 3/8/24 | NAUT | Nautilus Biotechnology, Inc. | Electr | LabEq | Laboratory Analytical Instrum | Patel Sujal M | WA | DOT | CEO,P,,S | P.m | 41 | 2.87 | 0 | 14 | 0 | 17,159 | D | |||||||||||||||
3/7/24 19:06 | 3/5/24 | NAUT | Nautilus Biotechnology, Inc. | Electr | LabEq | Laboratory Analytical Instrum | Patel Sujal M | WA | DOT | CEO,P,,S | P.m | 99 | 2.79 | 0 | 36 | 0 | 17,145 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |